HOME >> MEDICINE >> NEWS
First head-to-head study to compare lidoderm patch and Celebrex in treating pain

CHADDS FORD, Pa., March 31, 2005 Today at the 24th Annual Scientific Meeting of the American Pain Society, Endo Pharmaceuticals Inc. released new clinical trial data which found patients receiving either Lidoderm (lidocaine patch 5%) or Celebrex (celecoxib) 200 mg for pain associated with osteoarthritis (OA) of the knee experienced improvement in average daily pain intensity. Lidoderm is a topical analgesic patch approved by the U.S. Food and Drug Administration (FDA) in 1999 to treat the pain associated with post-herpetic neuralgia (PHN), a chronic condition resulting from nerve damage caused by shingles.

"The results of this exploratory study examining Lidoderm and Celebrex suggest that Lidoderm can alleviate the pain associated with osteoarthritis of the knee," said Alan Kivitz, M.D., of Altoona (Pa.) Center for Clinical Research. "I am encouraged by these findings since there is a critical need for new approaches to managing this type of pain."

OA affects more than 20 million Americans annually and generates more than seven million physician visits per year. If left untreated, chronic pain conditions such as OA can have significant physical, psychological and financial consequences by affecting daily functioning and quality of life.

Due to safety concerns regarding the entire COX-II inhibitor class in the fall of 2004, the sponsor of the study, Endo Pharmaceuticals Inc., voluntarily elected to prematurely halt the study prior to reaching the original enrollment target. However an analysis of data after six weeks of treatment showed that of the patients treated in the Lidoderm group (N=56), 54% experienced a 30% or greater improvement in average daily pain intensity; (studies have reported that 30% or greater reductions in pain intensity are clinically meaningful to pain patients). In the Celebrex group (N=63), 62% experienced a 30% or greater improvement in average daily pain intensity. In addition, clinically meaningfu
'"/>

Contact: Fiona Buraimoh
fiona_buraimoh@nyc.cohnwolfe.com
212-798-9512
Cohn & Wolfe
31-Mar-2005


Page: 1 2 3

Related medicine news :

1. First UK cases of previously rare disease reported in gay men
2. First mouse model for multiple system atrophy points to new treatment targets for brain diseases
3. Mayo Clinic researchers create obedient virus; First step to use measles virus against cancer
4. First US kidney cancer vaccine trial underway at Columbia
5. First new treatment for alcoholism in ten years, now available Campral(R) (acamprosate calcium)
6. First blood test to diagnose paralyzing, blinding disease
7. First US SARS vaccine trial opens at NIH
8. First-ever safety study of medical cannabis use in Canada launched
9. First solid evidence that the study of music promotes intellectual development
10. First medical test on CD gets good results
11. First proof that cutting Rx drugs due to cost harms health

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/8/2019)... ... , ... METAvivor Research and Support Inc., a non-profit organization dedicated to funding ... Stampede campaign. The campaign will commence with two days of action and education on ... camp, a march, a Die-In (hosted by partner MET-UP), and visits with Congressional offices. ...
(Date:10/8/2019)... ... October 08, 2019 , ... The ... a Digital Health Awards 1st Round (Top Ten) Finalist in its Best ... to select companies that promote faster, better, more cost-effective healthcare by improving outcomes ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... dentistry techniques, has recently attended an advanced Level III training in Cagliari, Italy, ... dentistry. The training took place September 16-19, 2019 at the Sardinia Dental Teaching ...
(Date:10/8/2019)... TORONTO (PRWEB) , ... October 08, 2019 , ... ... at a cost of $28 billion per year, are reproducible. Rigor in bioanalytical ... are increasingly outsourced (by some estimates, more than half of the time) and ...
(Date:10/8/2019)... ... October 08, 2019 , ... U.S. Oral ... that exclusively serves premier oral and maxillofacial surgeons – has formed a new ... practice with two locations near Knoxville, Tennessee. The partnership is USOSM’s first in ...
Breaking Medicine News(10 mins):
(Date:10/8/2019)... (PRWEB) , ... October 08, 2019 , ... Fresno resident ... Donate Life Rose Parade® Float living donor honoree. Regina will walk alongside the float, ... Day. , Regina, a retired nurse and attorney, became a living organ donor in ...
(Date:10/8/2019)... ... , ... Four things to know: , 1. The Hive™ ALIF interbody contains ... the lattice core. , 2. The Soft Titanium® lattice of HD LifeSciences ... growth throughout the implant. , 3. The Hive™ ALIF device can hold over 5cc ...
(Date:10/8/2019)... ... October 08, 2019 , ... Corteva Agriscience ... range of novel, microbial-based crop protection products. , Under the agreement, MicroMGx will ... points. In a first for the agriculture industry, Corteva will use those starting ...
Breaking Medicine Technology:
Cached News: